These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 27067660)

  • 1. Automation in Chinese bioanalytical CROs for sustained competitiveness and growth.
    Li M
    Bioanalysis; 2016 May; 8(9):941-3. PubMed ID: 27067660
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of the recession on bioanalysis.
    Abbott RW
    Bioanalysis; 2009 Sep; 1(6):1033-5. PubMed ID: 21083069
    [No Abstract]   [Full Text] [Related]  

  • 3. Meeting the challenges of bioanalytical outsourcing: understanding the hidden cost of price pressure.
    Bennett P
    Bioanalysis; 2011 Nov; 3(22):2491-3. PubMed ID: 22122596
    [No Abstract]   [Full Text] [Related]  

  • 4. The current skills gaps in analytical sciences are failing industry: debate at the 21st International Reid Bioanalytical Forum.
    Spooner N; Sangster T
    Bioanalysis; 2016 Jul; 8(14):1437-9. PubMed ID: 27314647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perspectives on gender parity in bioanalysis: an interview with Shefali Patel.
    Patel SR
    Bioanalysis; 2019 Apr; 11(7):667-669. PubMed ID: 30997814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perspectives on gender parity in bioanalysis: an interview with Stephanie Cape.
    Cape S
    Bioanalysis; 2019 Apr; 11(7):661-662. PubMed ID: 30997812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perspectives on gender parity in bioanalysis: an interview with Scott Summerfield.
    Summerfield SG
    Bioanalysis; 2019 Apr; 11(7):675-676. PubMed ID: 30997820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perspectives on gender parity in bioanalysis: an interview with Chad Briscoe.
    Briscoe C
    Bioanalysis; 2019 Apr; 11(7):659-660. PubMed ID: 30997817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perspectives on gender parity in bioanalysis: an interview with Katryn Allen.
    Allen K
    Bioanalysis; 2019 Apr; 11(7):655-656. PubMed ID: 30997823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Career management--by choice, by chance, or by crisis.
    Ellie PE
    J AHIMA; 1996; 67(7):54-6. PubMed ID: 10158573
    [No Abstract]   [Full Text] [Related]  

  • 11. The biotechnology sector's craving for commercial expertise is fuelling a cultural exchange with drug industry.
    Smaglik P; Frantz S
    Nature; 2003 Apr; 422(6931):542-3. PubMed ID: 12673255
    [No Abstract]   [Full Text] [Related]  

  • 12. Perspectives on gender parity in bioanalysis: an interview with Binodh DeSilva.
    De Silva B
    Bioanalysis; 2019 Apr; 11(7):663-664. PubMed ID: 30997822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outsourcing bioanalytical services at Janssen Research and Development: the sequel anno 2017.
    Dillen L; Verhaeghe T
    Bioanalysis; 2017 Aug; 9(15):1195-1201. PubMed ID: 28762758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Teva to acquire Chinese biogenerics manufacturer.
    Katsnelson A
    Nat Biotechnol; 2005 Jul; 23(7):765. PubMed ID: 16003343
    [No Abstract]   [Full Text] [Related]  

  • 15. AchemAsia 2007 announcement: China's biotechnology industry on the upswing.
    Biotechnol J; 2007 Mar; 2(3):288-90. PubMed ID: 17354215
    [No Abstract]   [Full Text] [Related]  

  • 16. Changing talent needs to realize biotech products.
    Rafferty MA
    Nat Biotechnol; 2004 Oct; 22(10):1327. PubMed ID: 15470474
    [No Abstract]   [Full Text] [Related]  

  • 17. Screening for drug discovery: the leading question.
    Smith A
    Nature; 2002 Jul; 418(6896):453-9. PubMed ID: 12140563
    [No Abstract]   [Full Text] [Related]  

  • 18. Current status of bioanalytical outsourcing: a pharma perspective.
    Bioanalysis; 2017 Aug; 9(15):1165-1169. PubMed ID: 28795582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. China calling.
    Nat Biotechnol; 2011 Feb; 29(2):89. PubMed ID: 21301414
    [No Abstract]   [Full Text] [Related]  

  • 20. Investor volatility plagues drug companies on new Chinese exchange.
    Mitchell P; Jing F
    Nat Biotechnol; 2010 Jan; 28(1):9-10. PubMed ID: 20062025
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.